127 related articles for article (PubMed ID: 2210688)
1. Heterogeneous expression of proto-oncogenes in Hodgkin's disease derived cell lines.
Jücker M; Schaadt M; Diehl V; Poppema S; Jones D; Tesch H
Hematol Oncol; 1990; 8(4):191-204. PubMed ID: 2210688
[TBL] [Abstract][Full Text] [Related]
2. The Met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma.
Jücker M; Günther A; Gradl G; Fonatsch C; Krueger G; Diehl V; Tesch H
Leuk Res; 1994 Jan; 18(1):7-16. PubMed ID: 8289471
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification.
Smithgall TE; Johnston JB; Bustin M; Glazer RI
J Natl Cancer Inst; 1991 Jan; 83(1):42-6. PubMed ID: 1984516
[TBL] [Abstract][Full Text] [Related]
4. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of Hodgkin's disease-derived cell lines.
Tesch H; Jücker M; Falk MH; Bornkamm GW; Jones DB; Diehl V
Hematol Oncol; 1988; 6(3):223-31. PubMed ID: 3136069
[TBL] [Abstract][Full Text] [Related]
6. Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin-derived cell lines: activation of immature lymphoid cells in Hodgkin's disease.
Falk MH; Tesch H; Stein H; Diehl V; Jones DB; Fonatsch C; Bornkamm GW
Int J Cancer; 1987 Aug; 40(2):262-9. PubMed ID: 3112032
[TBL] [Abstract][Full Text] [Related]
7. Expression of cellular oncogenes in primary cells from human acute leukemias.
Mavilio F; Sposi NM; Petrini M; Bottero L; Marinucci M; De Rossi G; Amadori S; Mandelli F; Peschle C
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4394-8. PubMed ID: 3520570
[TBL] [Abstract][Full Text] [Related]
8. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
9. Oncogenes in Hodgkin's disease.
Jones DB; Cossman J; Hansmann ML
Ann Oncol; 1992 Sep; 3 Suppl 4():9-12. PubMed ID: 1333273
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
[TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus-6 (HHV-6) in Hodgkin's disease: cellular expression of viral antigens as compared to oncogenes met and fes, tumor suppressor gene product p53, and interleukins 2 and 6.
Krueger GR; Guenther A; Knuefermann R; Kluppelberg U; Luka J; Pearson GR; Ablashi DV; Juecker M; Tesch H
In Vivo; 1994; 8(4):501-16. PubMed ID: 7893977
[TBL] [Abstract][Full Text] [Related]
12. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
13. Identification of peanut agglutinin binding glycoproteins restricted to Hodgkin's disease-derived cell lines.
Flavell DJ; Jones DB; Wright DH
Hematol Oncol; 1989; 7(3):207-17. PubMed ID: 2468595
[TBL] [Abstract][Full Text] [Related]
14. Proto-oncogene expression in avian hematopoietic tissues.
Schuur ER; Baluda MA
Oncogene; 1991 Aug; 6(8):1409-15. PubMed ID: 1886713
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques.
Mitani S; Sugawara I; Shiku H; Mori S
Cancer; 1988 Nov; 62(10):2085-93. PubMed ID: 3052780
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin and sternberg-reed cell antigen(s) detected by an antiserum to a cell line (L428) derived from Hodgkin's disease.
Stein H; Gerdes J; Kirchner H; Schaadt M; Diehl V
Int J Cancer; 1981 Oct; 28(4):425-9. PubMed ID: 6946981
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-myc and c-ras oncogenes in the neoplastic and non-neoplastic cells of Hodgkin's disease.
Benharroch D; Yermiahu T; Geffen DB; Prinsloo I; Gopas J; Segal S; Aboud M
Eur J Haematol; 1995 Sep; 55(3):178-83. PubMed ID: 7672090
[TBL] [Abstract][Full Text] [Related]
19. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
20. Cellular protein profiles of the Hodgkin's disease cell lines L428, KM-H2 and HDLM-2: a comparative study.
Hock BD; Hart DN
Leuk Res; 1992; 16(3):253-63. PubMed ID: 1560674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
